UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

The New England journal of medicine, 2014-07, Vol.371 (2), p.107-118

2014

Link zum Volltext

Verfügbarkeit prüfen

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Journal of clinical oncology, 2013-09, Vol.31 (25), p.3083-3090

2013

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer in the Elderly

Journal of clinical oncology, 2007-05, Vol.25 (14), p.1882-1890

2007

Link zum Volltext

Verfügbarkeit prüfen

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

Journal of clinical oncology, 2010-06, Vol.28 (18), p.2966-2973

2010

Link zum Volltext

Verfügbarkeit prüfen

Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial

Journal of clinical oncology, 2008-04, Vol.26 (12), p.1972-1979

2008

Link zum Volltext

Verfügbarkeit prüfen

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

Journal of clinical oncology, 2000-04, Vol.18 (7), p.1412-1422

2000

Link zum Volltext

Verfügbarkeit prüfen

The Role of the Number of Uninvolved Lymph Nodes in Predicting Locoregional Recurrence in Breast Cancer

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2019-2026

2007

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic management of breast cancer in the elderly

Expert opinion on pharmacotherapy, 2011-04, Vol.12 (6), p.945-960

2011

Link zum Volltext

Verfügbarkeit prüfen

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases

BMC cancer, 2005-07, Vol.5 (1), p.70-70, Article 70

2005

Link zum Volltext

Verfügbarkeit prüfen

Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience

Journal of clinical oncology, 2005-03, Vol.23 (7), p.1390-1400

2005

Link zum Volltext

Verfügbarkeit prüfen

Prognosis of women with primary breast cancer diagnosed during pregnancy

Journal of clinical oncology, 2014-01, Vol.32 (3), p.255-255

2014

Link zum Volltext

Verfügbarkeit prüfen

Target therapy in elderly breast cancer patients

Critical reviews in oncology/hematology, 2012-09, Vol.83 (3), p.422-431

2012

Link zum Volltext

Verfügbarkeit prüfen

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

The lancet oncology, 2018-10, Vol.19 (10), p.1385-1393

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Endocrine Therapy Compared With No Systemic Therapy for Elderly Women With Early Breast Cancer: 21-Year Results of International Breast Cancer Study Group Trial IV

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4517-4523

2003

Link zum Volltext

Verfügbarkeit prüfen

Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study

BMC cancer, 2010-05, Vol.10 (1), p.205-205, Article 205

2010

Link zum Volltext

Verfügbarkeit prüfen

Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?

Journal of clinical oncology, 2010-06, Vol.28 (16), p.e257; author reply e258-e257

2010

Link zum Volltext

Verfügbarkeit prüfen

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

Clinical cancer research, 2014-01, Vol.20 (2), p.456-468

2014

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics Biomarkers of Frailty in Elderly Breast Cancer Patients

Journal of cellular physiology, 2014-07, Vol.229 (7), p.898-902

2014

Link zum Volltext

Verfügbarkeit prüfen

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2―Positive, Locally Advanced, or Metastatic Breast Cancer

Journal of clinical oncology, 2014-05, Vol.32 (14), p.1437-1444

2014

Link zum Volltext

Verfügbarkeit prüfen

Breast carcinoma during pregnancy : International recommendations from an expert meeting

Cancer, 2006-01, Vol.106 (2), p.237-246

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-13-05: Role of pharmacogenetics in metastatic breast cancer (MBC) patients treated with exemestane as first-line hormonal therapy. An Italian multicentre study

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P1-P1-13-05

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Breast cancer research and treatment, 2007-03, Vol.101 (3), p.355-365

2007

Link zum Volltext

Verfügbarkeit prüfen

Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients

Clinical cancer research, 2000-06, Vol.6 (6), p.2279-2287

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Oncotarget, 2016-06, Vol.7 (26), p.39809-39822

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(87)

Publikationsform

Artikel
(107)
Buchkapitel
(2)

Sprache

Englisch
(109)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(90)
Science & Technology
(87)
Female
(85)
Life Sciences & Biomedicine
(85)
Oncology
(76)
Aged
(62)
Middle Aged
(59)
Breast Neoplasms - Drug Therapy
(49)
Adult
(47)
Biological And Medical Sciences
(36)
Medical Sciences
(36)
Breast Neoplasms - Pathology
(28)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Tumors
(24)
Breast Cancer
(23)
Treatment Outcome
(23)
Chemotherapy
(22)
Chemotherapy, Adjuvant
(22)
Male
(22)
Gynecology. Andrology. Obstetrics
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

Breast Cancer in the Elderly

Classical Cyclophosphamide, Methotrexate, and Fluorouracil Chemotherapy Is More Effective in Triple-Negative, Node-Negative Breast Cancer: Results From Two Randomized Trials of Adjuvant Chemoendocrine Therapy for Node-Negative Breast Cancer

Letrozole Compared With Tamoxifen for Elderly Patients With Endocrine-Responsive Early Breast Cancer: The BIG 1-98 Trial

Burdens and Benefits of Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil and Tamoxifen for Elderly Patients With Breast Cancer: The International Breast Cancer Study Group Trial VII

The Role of the Number of Uninvolved Lymph Nodes in Predicting Locoregional Recurrence in Breast Cancer

Therapeutic management of breast cancer in the elderly

Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases

Site of Primary Tumor Has a Prognostic Role in Operable Breast Cancer: The International Breast Cancer Study Group Experience

Prognosis of women with primary breast cancer diagnosed during pregnancy

Target therapy in elderly breast cancer patients

Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Adjuvant Endocrine Therapy Compared With No Systemic Therapy for Elderly Women With Early Breast Cancer: 21-Year Results of International Breast Cancer Study Group Trial IV

Late tamoxifen in patients previously operated for breast cancer without postoperative tamoxifen: 5-year results of a single institution randomised study

Small tumor size and node-negative HER2-positive breast cancer: a step forward for a better treatment?

Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy

Prognostic Value of Extracapsular Tumor Spread for Locoregional Control in Premenopausal Patients With Node-Positive Breast Cancer Treated With Classical Cyclophosphamide, Methotrexate, and Fluorouracil: Long-Term Observations From International Breast Cancer Study Group Trial VI

Metabolomics Biomarkers of Frailty in Elderly Breast Cancer Patients

Phase IIa Trial of Trastuzumab Emtansine With Pertuzumab for Patients With Human Epidermal Growth Factor Receptor 2―Positive, Locally Advanced, or Metastatic Breast Cancer

Breast carcinoma during pregnancy : International recommendations from an expert meeting

Abstract P1-13-05: Role of pharmacogenetics in metastatic breast cancer (MBC) patients treated with exemestane as first-line hormonal therapy. An Italian multicentre study

Randomized phase II trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

Dose-finding and Pharmacologic Study of Chronic Oral Idarubicin Therapy in Metastatic Breast Cancer Patients

Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer

Suchergebnisse filtern